bpc 157 hims BPC-157 – Alphaceuticals by Dr. Catherine HIMS ripped after an FDA
HIMS ripped after an FDA advisory panel backed adding BPC 157 to the 503A compounding list. That's not full approval, but it opens the door to a much larger peptide category. Hims already HIMS FDA PANEL VOTES 'YES' ON BPC 157 THE 8 PCAC PANELIST MEMBERS WHO VOTED YES: 1. Asare Christian 2. David Pope 3. Gabriel Alizaidy 4. Haleem Mohammed 5. Joshua Starbuck 6. Kris Wusterhausen 7. Melissa Loseke 8. Bobby Harshbarger HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



